| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |